サマリー

神経障害性疼痛治療の世界市場 2022-2026 年
Technavioは神経障害性疼痛治療市場を監視しており、2022-2026年の間に3.81億ドルの成長が見込まれ、予測期間中にCAGR 9.18%で加速しています。当レポートでは、神経障害性疼痛治療市場の全体分析、市場規模・予測、トレンド、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。帯状疱疹後神経痛の新規治療薬の開発に注力することが、市場を牽引しています。
神経障害性疼痛治療市場の分析には、タイプ別セグメントと地理的展望が含まれます。
Technavioの神経障害性疼痛治療市場は、以下のようにセグメント化されています。
タイプ別
- 糖尿病性ニューロパチー
- 化学療法誘発性ニューロパチー疼痛
- 帯状疱疹後神経痛
- その他
地域別構成比
- 北アメリカ
- 欧州
- アジア太平洋
- 南米
- 中東・アフリカ
本研究では、今後数年間の神経障害性疼痛治療市場の成長を促進する主要な理由の一つとして、神経障害性疼痛治療変化市場力学のための局所的なパッチの開発を識別しています。また、新興国への関心の高まりと、肥満と内分泌疾患との関連は、市場の大規模な需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、総括する方法で、主要パラメータの分析により、市場の詳細な姿を提示します。神経障害性疼痛治療市場に関する当レポートは、以下の分野を対象としています。
- 神経障害性疼痛治療市場のサイジング
- 神経障害性疼痛治療市場予測
- 神経障害性疼痛治療市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Abbott Laboratories、Assertio Therapeutics Inc.、Astellas Pharma Inc,AstraZeneca Plc、Aurobindo Pharma Ltd、Baxter International Inc、Biogen Inc、Bristol Myers Squibb Co、Dr. Reddys Laboratories Ltd、Eli Lilly and Co、Endo International Plc、GlaxoSmithKline Plc、Johnson and Johnson、Mallinckrodt Plc、Novartis AG、Pfizer Inc、Sanofi SA、Sun Pharmaceutical Industries Ltd、およびVistaGen Therapeutics Inc.などの大手ベンダーが含まれていることを、詳細な分析により明らかにしていきます。また、神経障害性疼痛治療市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/neuropathy-pain-treatment-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Indication
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Indication
o 5.1 Market segments
o Exhibit 24: Chart on Indication - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Indication - Market share 2021-2026 (%)
o 5.2 Comparison by Indication
o Exhibit 26: Chart on Comparison by Indication
o Exhibit 27: Data Table on Comparison by Indication
o 5.3 Diabetic neuropathy - Market size and forecast 2021-2026
o Exhibit 28: Chart on Diabetic neuropathy - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Diabetic neuropathy - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Diabetic neuropathy - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Diabetic neuropathy - Year-over-year growth 2021-2026 (%)
o 5.4 Chemotherapy-induced neuropathy pain - Market size and forecast 2021-2026
o Exhibit 32: Chart on Chemotherapy-induced neuropathy pain - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Chemotherapy-induced neuropathy pain - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Chemotherapy-induced neuropathy pain - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Chemotherapy-induced neuropathy pain - Year-over-year growth 2021-2026 (%)
o 5.5 Postherpetic neuralgia - Market size and forecast 2021-2026
o Exhibit 36: Chart on Postherpetic neuralgia - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Postherpetic neuralgia - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Postherpetic neuralgia - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Postherpetic neuralgia - Year-over-year growth 2021-2026 (%)
o 5.6 Others - Market size and forecast 2021-2026
o Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by Indication
o Exhibit 44: Market opportunity by Indication ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 APAC - Market size and forecast 2021-2026
o Exhibit 58: Chart on APAC - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on APAC - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on APAC - Year-over-year growth 2021-2026 (%)
o 7.6 South America - Market size and forecast 2021-2026
o Exhibit 62: Chart on South America - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on South America - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on South America - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on South America - Year-over-year growth 2021-2026 (%)
o 7.7 Middle East and Africa - Market size and forecast 2021-2026
o Exhibit 66: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
o 7.8 US - Market size and forecast 2021-2026
o Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.9 Germany - Market size and forecast 2021-2026
o Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 India - Market size and forecast 2021-2026
o Exhibit 86: Chart on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 87: Data Table on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 88: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 89: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.13 Market opportunity By Geographical Landscape
o Exhibit 90: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 91: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 93: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 94: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 95: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 96: Matrix on vendor position and classification
o 10.3 Abbott Laboratories
o Exhibit 97: Abbott Laboratories - Overview
o Exhibit 98: Abbott Laboratories - Business segments
o Exhibit 99: Abbott Laboratories - Key news
o Exhibit 100: Abbott Laboratories - Key offerings
o Exhibit 101: Abbott Laboratories - Segment focus
o 10.4 Assertio Therapeutics Inc.
o Exhibit 102: Assertio Therapeutics Inc. - Overview
o Exhibit 103: Assertio Therapeutics Inc. - Business segments
o Exhibit 104: Assertio Therapeutics Inc. - Key offerings
o Exhibit 105: Assertio Therapeutics Inc. - Segment focus
o 10.5 AstraZeneca Plc
o Exhibit 106: AstraZeneca Plc - Overview
o Exhibit 107: AstraZeneca Plc - Product / Service
o Exhibit 108: AstraZeneca Plc - Key news
o Exhibit 109: AstraZeneca Plc - Key offerings
o 10.6 Baxter International Inc.
o Exhibit 110: Baxter International Inc. - Overview
o Exhibit 111: Baxter International Inc. - Business segments
o Exhibit 112: Baxter International Inc. - Key news
o Exhibit 113: Baxter International Inc. - Key offerings
o Exhibit 114: Baxter International Inc. - Segment focus
o 10.7 Dr Reddys Laboratories Ltd
o Exhibit 115: Dr Reddys Laboratories Ltd - Overview
o Exhibit 116: Dr Reddys Laboratories Ltd - Business segments
o Exhibit 117: Dr Reddys Laboratories Ltd - Key offerings
o Exhibit 118: Dr Reddys Laboratories Ltd - Segment focus
o 10.8 Eli Lilly and Co.
o Exhibit 119: Eli Lilly and Co. - Overview
o Exhibit 120: Eli Lilly and Co. - Product / Service
o Exhibit 121: Eli Lilly and Co. - Key offerings
o 10.9 Endo International Plc
o Exhibit 122: Endo International Plc - Overview
o Exhibit 123: Endo International Plc - Business segments
o Exhibit 124: Endo International Plc - Key news
o Exhibit 125: Endo International Plc - Key offerings
o Exhibit 126: Endo International Plc - Segment focus
o 10.10 Johnson and Johnson
o Exhibit 127: Johnson and Johnson - Overview
o Exhibit 128: Johnson and Johnson - Business segments
o Exhibit 129: Johnson and Johnson - Key news
o Exhibit 130: Johnson and Johnson - Key offerings
o Exhibit 131: Johnson and Johnson - Segment focus
o 10.11 Pfizer Inc.
o Exhibit 132: Pfizer Inc. - Overview
o Exhibit 133: Pfizer Inc. - Product / Service
o Exhibit 134: Pfizer Inc. - Key news
o Exhibit 135: Pfizer Inc. - Key offerings
o 10.12 Sanofi SA
o Exhibit 136: Sanofi SA - Overview
o Exhibit 137: Sanofi SA - Business segments
o Exhibit 138: Sanofi SA - Key news
o Exhibit 139: Sanofi SA - Key offerings
o Exhibit 140: Sanofi SA - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 141: Inclusions checklist
o Exhibit 142: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 143: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 144: Research methodology
o Exhibit 145: Validation techniques employed for market sizing
o Exhibit 146: Information sources
o 11.5 List of abbreviations
o Exhibit 147: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Indication - Market share 2021-2026 (%)
Exhibits25: Data Table on Indication - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Indication
Exhibits27: Data Table on Comparison by Indication
Exhibits28: Chart on Diabetic neuropathy - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Diabetic neuropathy - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Diabetic neuropathy - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Diabetic neuropathy - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Chemotherapy-induced neuropathy pain - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Chemotherapy-induced neuropathy pain - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Chemotherapy-induced neuropathy pain - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Chemotherapy-induced neuropathy pain - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Postherpetic neuralgia - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Postherpetic neuralgia - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Postherpetic neuralgia - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Postherpetic neuralgia - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Indication ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on APAC - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on APAC - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on South America - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on South America - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on South America - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on South America - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits86: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits87: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits88: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits89: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits90: Market opportunity By Geographical Landscape ($ million)
Exhibits91: Impact of drivers and challenges in 2021 and 2026
Exhibits92: Overview on Criticality of inputs and Factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Vendors covered
Exhibits96: Matrix on vendor position and classification
Exhibits97: Abbott Laboratories - Overview
Exhibits98: Abbott Laboratories - Business segments
Exhibits99: Abbott Laboratories - Key news
Exhibits100: Abbott Laboratories - Key offerings
Exhibits101: Abbott Laboratories - Segment focus
Exhibits102: Assertio Therapeutics Inc. - Overview
Exhibits103: Assertio Therapeutics Inc. - Business segments
Exhibits104: Assertio Therapeutics Inc. - Key offerings
Exhibits105: Assertio Therapeutics Inc. - Segment focus
Exhibits106: AstraZeneca Plc - Overview
Exhibits107: AstraZeneca Plc - Product / Service
Exhibits108: AstraZeneca Plc - Key news
Exhibits109: AstraZeneca Plc - Key offerings
Exhibits110: Baxter International Inc. - Overview
Exhibits111: Baxter International Inc. - Business segments
Exhibits112: Baxter International Inc. - Key news
Exhibits113: Baxter International Inc. - Key offerings
Exhibits114: Baxter International Inc. - Segment focus
Exhibits115: Dr Reddys Laboratories Ltd - Overview
Exhibits116: Dr Reddys Laboratories Ltd - Business segments
Exhibits117: Dr Reddys Laboratories Ltd - Key offerings
Exhibits118: Dr Reddys Laboratories Ltd - Segment focus
Exhibits119: Eli Lilly and Co. - Overview
Exhibits120: Eli Lilly and Co. - Product / Service
Exhibits121: Eli Lilly and Co. - Key offerings
Exhibits122: Endo International Plc - Overview
Exhibits123: Endo International Plc - Business segments
Exhibits124: Endo International Plc - Key news
Exhibits125: Endo International Plc - Key offerings
Exhibits126: Endo International Plc - Segment focus
Exhibits127: Johnson and Johnson - Overview
Exhibits128: Johnson and Johnson - Business segments
Exhibits129: Johnson and Johnson - Key news
Exhibits130: Johnson and Johnson - Key offerings
Exhibits131: Johnson and Johnson - Segment focus
Exhibits132: Pfizer Inc. - Overview
Exhibits133: Pfizer Inc. - Product / Service
Exhibits134: Pfizer Inc. - Key news
Exhibits135: Pfizer Inc. - Key offerings
Exhibits136: Sanofi SA - Overview
Exhibits137: Sanofi SA - Business segments
Exhibits138: Sanofi SA - Key news
Exhibits139: Sanofi SA - Key offerings
Exhibits140: Sanofi SA - Segment focus
Exhibits141: Inclusions checklist
Exhibits142: Exclusions checklist
Exhibits143: Currency conversion rates for US$
Exhibits144: Research methodology
Exhibits145: Validation techniques employed for market sizing
Exhibits146: Information sources
Exhibits147: List of abbreviations